BridgeBio have substantially improved its development of an new therapy for ATTR-CM, employing Attruby. Initial trial data suggests significant outcomes for those suffering from a serious condition. The emphasis represents BridgeBio's focus to treating critical healthcare needs in a heart space. Attruby: BridgeBio's Novel Approach to Combatting AT